
Organometallics p. 3920 - 3922 (1992)
Update date:2022-08-17
Topics:
Brookhart
Grant
Volpe Jr.
A convenient synthesis of the easily handled, crystalline oxonium acid [(3,5-(CF3)2C6H3)4B] -[H(OEt2)2]+ (1) is described. The utility of this reagent for generation and stabilization of highly electrophilic cationic transition-metal complexes through protonation reactions is illustrated by the preparation of stable, ether-free salts of [C5Me5(P(OMe)3)CoCH2CH 2(μ-H)]+[(3,5-(CF3)2C 6H3)4B]- from C5Me5(P(OMe)3)Co(C2H4). The incorporation of the noncoordinating counterion [(3,5-(CF3)2C6H3)4B] - in organometallic salts has several advantages relative to [BF4]- and [PF6]-, including high stability and solubility in relatively nonpolar organic solvents.
Hubei Lansun Biochemical Pharmaceutical Co., Ltd
Contact:714-6395977
Address:No. 81 Pengcheng Avenue, economic and technological development zone, Huangshi City, Hubei Province,China
Chemvon Biotechnology Co. Ltd.
website:http://www.chemvon.com
Contact:86-21-58550039;86-21-31268550-8004
Address:Suite B-10#, 6999 Chuansha Road, Pudong District, Shanghai 201202, China
Shanghai Rainbow Chemistry Co., Ltd.
Contact:+86-21-64968086-5815/5812
Address:3rd floor, Building 7, 251 Faladi Road, Zhangjiang Hi-Tech Park, Pudong District, Shanghai, P.R. China
FOSHAN NANHAI ZHONGNAN PHARMACEUTICAL FACTORY
Contact:0086-0757-85609331
Address:XIAHENGTIAN INDUSTRIAL ZONE,SHAYONG VILLAGE,LISHUI TOWN
Jinan Decheng Hemu Medical Technology Co.,Ltd.
Contact:+86-531-68650525
Address:NO.554 Zhengfeng Road High-new Technology Development Zone
Doi:10.1039/d0ta05753c
(2020)Doi:10.1039/c39870001480
(1987)Doi:10.1021/ja981227l
(1999)Doi:10.1002/pssa.2210730132
(1982)Doi:10.1021/ic060235x
(2006)Doi:10.1007/BF01431115
(1996)